Back to Search
Start Over
m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
- Source :
- Molecular Cancer, Molecular Cancer, Vol 18, Iss 1, Pp 1-13 (2019)
- Publication Year :
- 2019
- Publisher :
- Springer Science and Business Media LLC, 2019.
-
Abstract
- Background N6-Methyladenosine (m6A) modification has been implicated in many biological processes. It is important for the regulation of messenger RNA (mRNA) stability, splicing, and translation. However, its role in cancer has not been studied in detail. Here we investigated the biological role and underlying mechanism of m6A modification in hepatoblastoma (HB). Methods We used Reverse transcription quantitative real-time PCR (RT-qPCR) and Western blotting to determine the expression of m6A related factors. And we clarified the effects of these factors on HB cells using cell proliferation assay, colony formation, apoptotic assay. Then we investigated of methyltransferase-like 13 (METTL3) and its correlation with clinicopathological features and used xenograft experiment to check METTL3 effect in vivo. m6A-Seq was used to profiled m6A transcriptome-wide in hepatoblastoma tumor tissue and normal tissue. Finally, methylated RNA immunoprecipitation (MeRIP) assay, RNA remaining assay to perform the regulator mechanism of MEETL3 on the target CTNNB1 in HB. Results In this research, we discovered that m6A modifications are increased in hepatoblastoma, and METTL3 is the main factor involved with aberrant m6A modification. We also profiled m6A across the whole transcriptome in hepatoblastoma tumor tissues and normal tissues. Our findings suggest that m6A is highly expressed in hepatoblastoma tumors. Also, m6A is enriched not only around the stop codon, but also around the coding sequence (CDS) region. Gene ontology analysis indicates that m6A mRNA methylation contributes significantly to regulate the Wnt/β-catenin pathway. Reduced m6A methylation can lead to a decrease in expression and stability of the CTNNB1. Conclusion Overall our findings suggest enhanced m6A mRNA methylation as an oncogenic mechanism in hepatoblastoma, METTL3 is significantly up-regulated in HB and promotes HB development. And identify CTNNB1 as a regulator of METTL3 guided m6A modification in HB.
- Subjects :
- Hepatoblastoma
0301 basic medicine
Cancer Research
Biology
lcsh:RC254-282
Transcriptome
03 medical and health sciences
0302 clinical medicine
medicine
Wnt/β-catenin pathway
Coding region
CTNNB1
Messenger RNA
Research
Wnt signaling pathway
RNA
Methylation
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.disease
Molecular biology
030104 developmental biology
Oncology
030220 oncology & carcinogenesis
RNA m6A methylation
METTL3
Molecular Medicine
MRNA methylation
Subjects
Details
- ISSN :
- 14764598
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Molecular Cancer
- Accession number :
- edsair.doi.dedup.....bbbc7074479cdef13828779eca1c5d6d